My cynical self often wonders if the directors issue you mention is same as the deals. Ie with deals they never demanded a lot of cash so wasnt such a big deal to get the commitment. Hence we can talk about all the major pharma we signed up but reality is it seems there was maybe nothing more than taking a look aas no great financial commitment.
Maybe same with directors as many seem to be on multiple boards and if someone offers these guys a handful of cash to "be on the board" I'm tipping that is what they do, jump on board in name at least. We get to spruik all our major pharma partners and our influential board members, but it feels like in reality they may all just be bumper stickers with no real content.
To get them to actually buy in and do anything substasntial may be a whole different thing. Even now with Mr Hayes based in USA I am not sure is he specifically and only working for pyc, or another on multiple boards and who knows how much of his day goes to pyc. I am assuming he is full time at 500k pa but don' know.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)